Agarwal, Rajiv;
Hauske, Sibylle Jenny;
Wheeler, David C;
Doi, Kent;
Elsaesser, Amelie;
Ritter, Ivana;
Steubl, Dominik;
(2022)
Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in >15 000 individuals.
Diabetes, Obesity and Metabolism
, 24
(7)
pp. 1390-1393.
10.1111/dom.14694.
Preview |
Text
Wheeler_Diabetes Obesity Metabolism - 2022 - Agarwal - Empagliflozin and incidence of events consistent with acute kidney injury .pdf Download (350kB) | Preview |
Type: | Article |
---|---|
Title: | Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in >15 000 individuals |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1111/dom.14694 |
Publisher version: | https://doi.org/10.1111/dom.14694 |
Language: | English |
Additional information: | Copyright © 2022 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
Keywords: | SGLT2 inhibitor, kidney disease |
UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Renal Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine |
URI: | https://discovery.ucl.ac.uk/id/eprint/10145676 |
Archive Staff Only
![]() |
View Item |